Mutagenicity of the racemic mixtures of butadiene monoepoxide and butadiene diepoxide at the Hprt locus of T-lymphocytes following inhalation exposures of female mice and rats

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 429, Issue 1, 1999, Pages 127-140

  Meng, Quanxin ^a,b   Henderson, Rogene F ^c   Walker, Dale M ^a   Bauer, Michael J ^a,b   Reilly, Andrew A ^a,b   Walker, Vernon E ^a,b  

^a WADSWORTH CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

1,3 Butadiene; Butadiene diepoxide; Butadiene monoepoxide; Hprt; Lymphocyte; Mutagenicity

Indexed keywords

1,2 EPOXY 3 BUTENE; 1,3 BUTADIENE; BUTADIENE DIEPOXIDE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTOXICITY; INHALATION; METABOLITE; MOUSE; MUTAGENICITY; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; RACEMIC MIXTURE; RAT; T LYMPHOCYTE;

ADMINISTRATION, INHALATION; ANIMALS; CLONE CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOXY COMPOUNDS; FEMALE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MICE; MUTAGENICITY TESTS; MUTAGENS; MUTATION; RATS; RATS, INBRED F344; SPECIES SPECIFICITY; SPLEEN; STEREOISOMERISM; T-LYMPHOCYTES; TIME FACTORS;

ANIMALIA; RODENTIA;

EID: 0032839824     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(99)00105-0     Document Type: Article

References (35)

1. Himmelstein M.W., Acquavella J.F., Recio L., Medinsky M.A., Bond J.A. Toxicology and epidemiology of 1,3-butadiene. Crit. Rev. Toxicol. 27:1997;1-108.
2. Himmelstein M.W., Turner M.J., Asgharian B., Bond J.A. Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation. Carcinogenesis. 15:1994;1479-1486.
3. Himmelstein M.W., Turner M.J., Asgharian B., Bond J.A. Metabolism of 1,3-butadiene: inhalation pharmacokinetics and tissue dosimetry of butadiene epoxides in rats and mice. Toxicology. 113:1996;306-309.
4. Thornton-Manning J.R., Dahl A.R., Bechtold W.E., Griffith W.C. Jr., Henderson R.F. Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene. Carcinogenesis. 16:1995;1723-1731.
5. Nieusma J.L., Claffeym D.J., Maniglier-Poulet C., Imiolczyk T., Ross D., Ruth J.A. Stereochemical aspects of 1,3-butadiene metabolism and toxicity in rat and mouse liver microsomes and freshly isolated rat hepatocytes. Chem. Res. Toxicol. 10:1997;450-456.
6. H. Koc, N.Y. Tretyakova, V.E. Walker, J.A. Swenberg, Molecular dosimetry of N-7-guanine adduct formation in mice and rats exposed to 1,3-butadiene, Chem. Res. Toxicol., in press.
7. Wistuba D., Schurig V. Complimentary epoxide hydrolyase- vs. glutathion-S-transferase-catalyzed kinetic resolution of simple aliphatic oxiranes-complete regio-and enantioselective hydrolysis of cis-2-ethyl-3-methyloxirane. Agnew. Chem. Int. Ed. 25:1986;1032-1034.
8. Elfarra A.A., Krause R.J., Selzer R.R. Biochemistry of 1,3-butadiene metabolism and its relevance to 1,3-butadiene-induced carcinogenicity. Toxicology. 113:1996;23-30.
9. Krause R.J., Elfarra A.A. Oxidation of butadiene monoepoxide to meso- and (±)-diepoxybutane by cDNA-expressed human cytochrome P450s and by mouse, rat, and human liver microsomes: evidence for preferential hydration of meso-diepoxybutane in rat and human liver microsomes. Arch. Biochem. Biophys. 337:1997;176-184.
10. Meng Q., Recio L., Reilly A.A., Wong B., Bauer M., Walker V.E. Comparison of the mutagenic potency of 1,3-butadiene at the hprt locus of T-lymphocytes following inhalation exposure of female B6C3F1 mice and F344 rats. Carcinogenesis. 19:1998;1019-1027.
11. Meng Q., Henderson R.F., Chen T., Heflich R.H., Walker D.M., Bauer M.J., Reilly A.A., Walker V.E. Mutagenicity of 1,3-butadiene at the Hprt locus of T-lymphocytes following inhalation exposures of female mice and rats. Mutat. Res. 429:1999;107-125.
12. Cochrane J.E., Skopek T.R. Mutagenicity of butadiene and its epoxide metabolites. I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts. Carcinogenesis. 15:1994;719-723.
13. Medinsky M.A., Leavens T.L., Csanady G.A., Gargas M.L., Bond J.A. In vivo metabolism of butadiene by mice and rats: a comparison of physiological model predictions and experimental data. Carcinogenesis. 15:1994;1329-1340.
14. Henderson R.F., Thornton-Manning J.R., Bechtold W.E., Dahl A.R. Metabolism of 1,3-butadiene: species differences. Toxicology. 113:1996;17-22.
15. Skopek T.R., Walker V.E., Cochrane J.E., Craft T.R., Cariello N.F. Mutational spectrum of N-ethyl-N-nitrosourea at the hprt locus in splenic T-cells of exposed B6C3F1 mice. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7866-7870.
16. Walker V.E., Skopek T.R. A mouse model for the study of in vivo mutational spectra: Sequence specificity of ethylene oxide at the hprt locus. Mutat. Res. 288:1993;151-162.
17. Meng Q., Skopek T.R., Walker D.M., Hurley-Leslie S., Walker V.E. Culture and propagation of Hprt mutant T-lymphocytes isolated from mouse spleen. Environ. Mol. Mutagen. 32:1998;236-243.
18. Henderson R.F., Benson J.M., Hahn F.F., Barr E.B., Bechtold W.E., Burt D.G., Dahl A.R. Acute toxicity of butadiene diepoxide in B6C3F1 mice and Sprague-Dawley rats. The Toxicologist. 36(1):1997;177. Part 2.
19. Aidoo A., Lyn-Cook L.E., Mittelstaedt R.A., Heflich R.H., Casciano D.A. Induction of 6-thioguanine-resistant lymphocytes in Fischer 344 rats following in vivo exposure to N-ethyl-N-nitrosourea and cyclophosphamide. Environ. Mol. Mutagen. 17:1991;141-151.
20. Aidoo A., Lyn-Cook L.E., Heflich R.H., George E.O., Casciano D.A. The effect of time after treatment, treatment schedule and animal age on the frequency of 6-thioguanine-resistant T-lymphocytes induced in Fischer 344 rats by N-ethyl-N-nitrosourea. Mutat. Res. 298:1993;169-178.
21. Cochrane J.E., Skopek T.R. Mutagenicity of butadiene and its epoxide metabolites. II: Mutational spectrum of butadiene, 1,2-epoxybutene and diepoxybutane at the hprt locus in splenic T cells from exposed B6C3F1 mice. Carcinogenesis. 15:1994;719-723.
22. Walker V.E., Gorelick N.J., Andrews J.L., Craft T.R., deBoer J.G., Glickman B.W., Skopek T.R. Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice. Cancer Res. 56:1996;4654-4661.
23. Tates A.D., van Dam F.J., van Teylingen C.M.M., de Zwart F.A., Zwinderman A.H. Comparison of induction of hprt mutations by 1,3-butadiene and/or its 1,2-epoxybutene and 1,2,3,4-diepoxybutane in lymphocytes from spleen of adult male mice and rats in vivo. Mutat. Res. 397:1998;21-36.
24. Saranko C.J., Pluta L.J., Recio L., Henderson R.F. In vivo and in vitro mutagenicity spectrum of the butadiene metabolite 1,2-epoxybutene. Proc. Am. Assoc. Cancer Res. 39:1998;330.
25. Sisk S., Pluta L.J., Meyer K.G., Recio L. Assessment of the in vivo mutagenicity of ethylene oxide in the tissue of B6C3F1 lacI trangenic mice following inhalation exposure. Mutat. Res. 391:1997;153-164.
26. Walker V.E., Sisk S.C., Upton P.B., Wong B.A., Recio L. In vivo mutagenicity of ethylene oxide at the hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure. Mutat. Res. 392:1997;211-222.
27. Andrews J.L., Walker V.E., Upton P.B., deBoer J.G., Gorelick N.J. Cyclophosphamide-induced mutations are detected at the hprt but not the lacI loci in splenic T-cells of exposed Big Blue® mice. Environ. Mol. Mutagen. 27:1996;4. Suppl. 27.
28. L. Recio, R.F. Henderson, L.J. Pluta, K. Meyer, C.J. Saranko, A.-M. Steen, Analysis of mutagenicity and determination of mutational spectrum in rodent and human cells to assess the roles of epoxybutene and diepoxybutane in mediating the in vivo genotoxicity of 1,3-butadiene, The Fourteen Health Effects Institute Annual Conference, 1998, p. 49.
29. Steen A.-M., Meyer K.G., Recio L. Analysis of hprt mutations occurring in human TK6 lymphoblastoid cells following exposure to 1,2,3,4-diepoxybutane. Mutagenesis. 12:1997;61-67.
30. Boogaard P.J., Bond J.A. The role of hydrolysis in the detoxification of 1,2,3,4-diepoxybutane by human, rat, and mouse liver and lung in vitro. Toxicol. Appl. Pharmacol. 141:1996;617-627.
31. Tates A.D., van Dam F.J., de Zwart F.A., van Teylingen C.M.M., Natarajan A.T. Development of a cloning assay with high cloning efficiency to detect induction of 6-thioguanine-resistant lymphocytes in spleen of adult mice following in vivo inhalation exposure to 1,3-butadiene. Mutat. Res. 309:1994;299-306.
32. V.E. Walker, I.M. Jones, T.L. Crippen, Q. Meng, D.M. Walker, M.J. Bauer, A.A. Reilly, A.D. Tates, J. Nakamura, P.B. Upton, T.R. Skopek, Molecular dosimetry ... and manifestation of Hprt mutant T-cells following treatment of preweanling, weanling, and adult mice, Mutat. Res., in press.
33. Thornton-Manning J.R., Dahl A.R., Allen M.L., Bechtold W.E., Griffith W.C. Jr., Henderson R.F. Disposition of butadiene epoxides in Sprague-Dawley rats following exposures to 8000 ppm 1,3-butadiene: comparisons with tissue epoxide concentrations following low-level exposures. Toxicol. Sci. 41:1998;167-173.
34. P. Koivisto, I. Kilpeläinen, I. Rasanen, I.-D. Adler, F. Pacchierotti, K. Pelton, Butadiene diolepoxide- and diepoxybutaine-derived DNA adducts at N7-guanne: a high occurrence of diolepoxide-derived adducts in mouse lung after 1,3-butadiene exposure. Carcinogenesis, in press.
35. Oe T., Kambouris S.J., Walker V.E., Meng Q., Recio L., Wherli S., Chaudhary A.K., Blair I.A. Persistence of 1,3:3,4-diepoxybutane N-7-guanine adducts in the tissue of mice exposed to 1,3-butadiene compared with rats. Chem. Res. Toxicol. 12:1999;247-257.